See more : Wolftank-Adisa Holding AG (WOLF.VI) Income Statement Analysis – Financial Results
Complete financial analysis of Epigral Limited (EPIGRAL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Epigral Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- Shanghai Yaohua Pilkington Glass Group Co., Ltd. (600819.SS) Income Statement Analysis – Financial Results
- FirstRand Limited (FSR.JO) Income Statement Analysis – Financial Results
- Diligent Media Corporation Limited (DNAMEDIA.BO) Income Statement Analysis – Financial Results
- Founder SPAC (FOUNW) Income Statement Analysis – Financial Results
- Tatton Asset Management plc (TAM.L) Income Statement Analysis – Financial Results
Epigral Limited (EPIGRAL.BO)
About Epigral Limited
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also trades in agrochemical products. The company serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.97B | 21.88B | 15.51B | 8.26B | 6.10B | 7.10B | 5.97B | 3.92B | 3.98B | 3.52B |
| Cost of Revenue | 11.59B | 11.15B | 7.61B | 4.12B | 2.92B | 2.69B | 2.49B | 1.75B | 1.81B | 1.90B |
| Gross Profit | 7.38B | 10.74B | 7.90B | 4.13B | 3.18B | 4.41B | 3.49B | 2.17B | 2.17B | 1.62B |
| Gross Profit Ratio | 38.91% | 49.06% | 50.93% | 50.06% | 52.12% | 62.12% | 58.37% | 55.32% | 54.44% | 45.94% |
| Research & Development | 7.62M | 7.62M | 7.62M | 5.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 69.97M | 62.70M | 47.12M | 38.47M | 19.82M | 18.12M | 13.59M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 256.61M | 293.64M | 170.19M | 44.98M | 46.84M | 67.64M | 19.64M | 0.00 | 0.00 | 0.00 |
| SG&A | 1.02B | 753.54M | 217.31M | 83.45M | 66.65M | 85.76M | 33.22M | 149.96M | 119.60M | 101.81M |
| Other Expenses | 0.00 | 79.84M | 41.11M | 5.89M | 75.00K | -68.98M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.03B | 4.94B | 3.66B | 2.26B | 1.67B | 1.82B | 1.48B | 1.29B | 1.12B | 943.97M |
| Cost & Expenses | 12.62B | 16.08B | 11.27B | 6.38B | 4.59B | 4.51B | 3.97B | 3.04B | 2.93B | 2.85B |
| Interest Income | -6.46M | 8.43M | 1.59M | 1.48M | 1.39M | 14.00M | 2.90M | 132.17M | 172.68M | 247.89M |
| Interest Expense | 623.34M | 655.02M | 442.70M | 309.01M | 78.02M | 25.14M | 77.45M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.24B | 1.09B | 859.06M | 735.45M | 443.02M | 540.99M | 552.72M | 554.30M | 440.51M | 423.03M |
| EBITDA | 4.77B | 6.98B | 5.17B | 2.66B | 1.97B | 3.13B | 2.55B | 1.44B | 1.49B | 1.09B |
| EBITDA Ratio | 25.12% | 31.85% | 33.12% | 31.35% | 30.56% | 42.37% | 42.63% | 36.74% | 37.40% | 31.01% |
| Operating Income | 6.68B | 5.68B | 4.27B | 1.97B | 1.54B | 2.57B | 1.99B | 886.32M | 1.05B | 667.70M |
| Operating Income Ratio | 35.19% | 25.96% | 27.55% | 23.89% | 25.26% | 36.23% | 33.37% | 22.61% | 26.34% | 18.98% |
| Total Other Income/Expenses | -3.77B | -3.49B | -2.45B | -2.22B | -104.43M | -167.86M | -49.10M | -135.86M | -171.18M | -1.09B |
| Income Before Tax | 2.91B | 5.22B | 3.83B | 1.61B | 1.41B | 2.42B | 1.95B | 750.47M | 877.53M | 424.34M |
| Income Before Tax Ratio | 15.33% | 23.87% | 24.72% | 19.48% | 23.11% | 34.12% | 32.69% | 19.14% | 22.04% | 12.06% |
| Income Tax Expense | 948.84M | 1.69B | 1.31B | 600.19M | 289.95M | 594.84M | 396.94M | 85.07M | 205.71M | 77.50M |
| Net Income | 1.96B | 3.53B | 2.53B | 1.01B | 1.12B | 1.83B | 1.55B | 665.40M | 671.82M | 346.85M |
| Net Income Ratio | 10.32% | 16.14% | 16.30% | 12.21% | 18.36% | 25.74% | 26.04% | 16.97% | 16.87% | 9.86% |
| EPS | 47.14 | 85.03 | 60.84 | 24.27 | 27.69 | 44.00 | 37.42 | 9.40 | 9.49 | 4.90 |
| EPS Diluted | 47.14 | 85.03 | 60.84 | 17.26 | 19.65 | 44.00 | 37.42 | 9.40 | 9.49 | 4.90 |
| Weighted Avg Shares Out | 41.55M | 41.55M | 41.55M | 41.55M | 41.19M | 41.55M | 41.55M | 70.76M | 70.76M | 70.76M |
| Weighted Avg Shares Out (Dil) | 41.55M | 41.55M | 41.55M | 58.43M | 58.07M | 41.55M | 41.55M | 70.76M | 70.76M | 70.76M |
Source: https://incomestatements.info
Category: Stock Reports